Maravai Lifesciences Holdings: Pay

Maravai Lifesciences Holdings paid its 7 named executives $24.0M in total in FY2025 (Dec). CEO Bernd Brust was paid $10.1M of that.

Pay$100 in the stock at the end of FY24 → $60
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Bernd BrustChief Executive Officer
FY2025 (Dec)
1 year
William E. Martin, IIIFormer Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Raj AsarpotaChief Financial Officer
FY2025 (Dec)
1 year
Peter Leddy, PhDChief Administrative Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Kevin HerdeFormer Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Kurt OreshackSecretary and General Counsel
FY2025 (Dec)
1 year
Christine DolanExecutive Vice President and General Manager, Cygnus
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 10 peers with pay on file was $7.8M. CEO pay of Maravai Lifesciences Holdings for that year is not on file.

  1. 1Halozyme Therapeutics
  2. 2Natera
  3. 3Twist Bioscience
  4. 4Sotera Health
  5. 5BIO-TECHNE
  6. 6Veracyte
  7. 710x Genomics
  8. 8Fulgent Genetics
  9. 9Repligen
  10. 10Cytek Biosciences
  11. 11Maravai Lifesciences HoldingsNot disclosed
  12. 12AzentaNot disclosed
  13. 13Guardant HealthNot disclosed
  14. 14Lantheus HoldingsNot disclosed
  15. 15NeogenomicsNot disclosed
  16. 16NeogenNot disclosed
  17. 17Tandem Diabetes CareNot disclosed
  18. 18iRythm TechnologiesNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.